GOLDMAN SACHS GROUP INC - INSTIL BIO INC ownership

INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 62 filers reported holding INSTIL BIO INC in Q2 2023. The put-call ratio across all filers is 0.12 and the average weighting 1.6%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of INSTIL BIO INC
ValueSharesWeighting
Q3 2023$13,577
-28.9%
31,721
-8.4%
0.00%
Q2 2023$19,086
-93.4%
34,639
-92.1%
0.00%
Q1 2023$288,611
-11.1%
436,759
-15.2%
0.00%
Q4 2022$324,609
+24985.7%
515,253
+92.6%
0.00%
Q3 2022$1,294
+12.0%
267,500
+7.0%
0.00%
Q2 2022$1,155
-99.9%
249,950
+189.2%
0.00%
Q1 2022$929,000
-33.6%
86,430
+5.7%
0.00%
Q4 2021$1,399,000
+632.5%
81,772
+667.2%
0.00%
Q3 2021$191,000
-93.5%
10,659
-91.0%
0.00%
-100.0%
Q1 2021$2,957,000117,8850.00%
Other shareholders
INSTIL BIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
CPMG Inc 8,478,790$151,558,00016.71%
VR Adviser, LLC 6,865,076$122,713,00015.76%
Vivo Capital, LLC 12,486,787$223,201,00010.02%
Samsara BioCapital, LLC 2,145,395$38,349,0006.02%
Fairmount Funds Management LLC 673,905$12,046,0004.38%
Logos Global Management LP 1,277,091$22,828,0001.65%
RA Capital Management 4,870,793$87,065,0001.21%
Nicholas Investment Partners, LP 679,171$12,140,0000.89%
HighVista Strategies LLC 72,079$1,288,0000.85%
Parametrica Management Ltd 46,225$826,0000.62%
View complete list of INSTIL BIO INC shareholders